Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use REVATIO safely and effectively. See full prescribing information for REVATIO. REVATIO (sildenafil) tablets, for oral useREVATIO (sildenafil) for oral suspensionREVATIO (sildenafil) injection, for intravenous use Initial U.S. Approval: 1998
Medication labelWhy this: Advisory · dailymed-prescription
Adults REVATIO is indicated for the treatment of pulmonary arterial hypertension (PAH) (World Health Organization [WHO] Group I) in adults to improve exercise ability and delay clinical worsening [see Clinical Studies (14)]. Pediatric Patients (1 to 17 Years old) REVATIO is indicated in pediatric patients 1 to 17 years old for the treatment of pulmonary arterial hypertension (PAH) (WHO Group I) to improve exercise ability and, in pediatric patients too young to perform standardized exercise testing, pulmonary hemodynamics thought to underlie improvements in exercise [see Clinical Studies (14)].
- generic_name
- sildenafil citrate
- product_names
- sildenafil citrate
- ndc
- 0069-4190, 0069-4190-68, 0069-0338, 0069-0338-01, 0069-0336, 0069-0336-21
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en